ASO Therapy

Concept

Antisense oligonucleotide therapy, a genetic approach in early trials that stops the liver from making apoprotein(a), thereby reducing Lp(a) levels.

Mentioned in 1 video

Videos Mentioning ASO Therapy

#129 - Tom Dayspring, M.D.: The latest insights into cardiovascular disease and lipidology

#129 - Tom Dayspring, M.D.: The latest insights into cardiovascular disease and lipidology

Peter Attia MD

Antisense oligonucleotide therapy, a genetic approach in early trials that stops the liver from making apoprotein(a), thereby reducing Lp(a) levels.